Cancer Informatics in 2018: The Mysteries of the Cancer Genome Continue to Unravel, Deep Learning Approaches the Clinic, and Passive Data Collection Demonstrates Utility

 

 Permissions and Reprints

Summary

Objective: To summarize significant research contributions on cancer informatics published in 2018.

Methods: An extensive search using PubMed/Medline, Google Scholar, and manual review was conducted to identify the scientific contributions published in 2018 that address topics in cancer informatics. The selection process comprised three steps: (i) 15 candidate best papers were first selected by the two section editors, (ii) external reviewers from internationally renowned research teams reviewed each candidate best paper, and (iii) the final selection of four best papers was conducted by the editorial board of the International Medical Informatics Association (IMIA) Yearbook.

Results: The four selected best papers present studies addressing many facets of cancer informatics, with immediate applicability in the translational and clinical domains.

Conclusion: Cancer informatics is a broad and vigorous subfield of biomedical informatics. Progress in cancer genomics, artificial intelligence, and passively collected data is especially notable in 2018.

• References

• 1 Lamy JB, Seroussi B, Griffon N, Kerdelhue G, Jaulent MC, Bouaud J. Toward a formalization of the process to select IMIA Yearbook best papers. Methods Inf Med 2015; 54 (02) 135-44
  Article in Thieme ConnectPubMedGoogle Scholar
• 2 Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A. , et al. Comprehensive characterization of cancer driver genes and mutations. Cell 2018; 173 (02) 371-385 e18
  CrossrefPubMedGoogle Scholar
• 3 Hosny A, Parmar C, Coroller TP, Grossmann P, Zeleznik R, Kumar A. , et al. Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study. PLoS Med 2018; 15 (11) e1002711
  CrossrefPubMedGoogle Scholar
• 4 Ardila D, Kiraly AP, Bharadwaj S, Choi B, Reicher JJ, Peng L. , et al. End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography. Nat Med 2019; 25 (06) 954-61
  CrossrefPubMedGoogle Scholar
• 5 Low CA, Dey AK, Ferreira D, Kamarck T, Sun W, Bae S. , et al. Estimation of symptom severity during chemotherapy from passively sensed data: Exploratory study. J Med Internet Res 2017; 19 (12) e420
  CrossrefPubMedGoogle Scholar
• 6 Liao Y, Thompson C, Peterson S, Mandrola J, Beg MS. The future of wearable technologies and remote monitoring in health care. Am Soc Clin Oncol Ed Book 2019; 39: 115-21
  PubMedGoogle Scholar
• 7 Tamborero D, Rubio-Perez C, Deu-Pons J, Schroeder MP, Vivancos A, Rovira A. , et al. Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations. Genome Med 2018; 10 (01) 25
  CrossrefPubMedGoogle Scholar
• 8 AACR Project GENIE Consortium. AACR Project GENIE: Powering precision medicine through an international consortium. Cancer Discov 2017; 7 (08) 818-31
  CrossrefPubMedGoogle Scholar
• 9 Baker S, Ali I, Silins I, Pyysalo S, Guo Y, Hogberg J. , et al. Cancer Hallmarks Analytics Tool (CHAT): a text mining approach to organize and evaluate scientific literature on cancer. Bioinformatics 2017; 33 (24) 3973-81
  CrossrefPubMedGoogle Scholar
• 10 Gianni M, Qin Y, Wenes G, Bandstra B, Conley AP, Subbiah V. , et al. High-throughput architecture for discovering combination cancer therapeutics. JCO Clin Cancer Inform 2018; 2: 1-12
  Google Scholar
• 11 Bertrand D, Drissler S, Chia BK, Koh JY, Li C, Suphavilai C. , et al. ConsensusDriver improves upon individual algorithms for predicting driver alterations in different cancer types and individual patients. Cancer Res 2018; 78 (01) 290-301
  CrossrefPubMedGoogle Scholar
• 12 Sun JX, He Y, Sanford E, Montesion M, Frampton GM, Vignot S. , et al. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal. PLoS Comput Biol 2018; 14 (02) e1005965
  PubMedGoogle Scholar
• 13 Piñeiro-Yáñez E, Reboiro-Jato M, Gómez-López G, Perales-Patón J, Troulé K, Rodríguez JM. , et al. PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data. Genome Med 2018; 10 (01) 41
  CrossrefPubMedGoogle Scholar
• 14 Cario CL, Witte JS. Orchid: a novel management, annotation and machine learning framework for analyzing cancer mutations. Bioinformatics 2018; 34 (06) 936-42
  CrossrefPubMedGoogle Scholar
• 15 Warner JL, Prasad I, Bennett M, Arniella M, Beeghly-Fadiel A, Mandl KD. , et al. SMART Cancer Navigator: A framework for implementing ASCO workshop recommendations to enable precision cancer medicine. JCO Precis Oncol 2018; 2: 1-14
  CrossrefPubMedGoogle Scholar
• 16 Malty AM, Jain SK, Yang PC, Harvey K, Warner JL. Computerized approach to creating a systematic ontology of hematology/oncology regimens. JCO Clin Cancer Inform 2018; 2: 1-11
  Google Scholar
• 17 Pecora AL, Norden AD, Hervey J, Schultz EV, Gallucci TL, Rushforth E. , et al. Development of a precise, clinically relevant, digital classification schema for cancer. JCO Clin Cancer Inform 2018; 2: 1-10
  Google Scholar
• 18 Gupta A, Stewart T, Bhulani N, Dong Y, Rahimi Z, Crane K. , et al. Feasibility of wearable physical activity monitors in patients with cancer. JCO Clin Cancer Inform 2018; 2: 1-10
  Google Scholar
• 19 Gustafson DH, DuBenske LL, Atwood AK, Chih MY, Johnson RA, McTavish F. , et al. Reducing symptom distress in patients with advanced cancer using an e-alert system for caregivers: Pooled analysis of two randomized clinical trials. J Med Internet Res 2017; 19 (11) e354
  CrossrefPubMedGoogle Scholar